- Executive
Biography
Greg Milosevich has a deep understanding of the Danaher Business System, a strong track record of driving growth across multiple Danaher Operating Companies and proven experience successfully transitioning acquisitions into Danaher. He is passionate about working collaboratively across the business to accelerate the discovery and development of new drugs and therapeutics to improve health and well-being for all.
Timeline
Greg joined Danaher in 2010 through the acquisition of Molecular Devices and has held roles of increasing responsibility across multiple businesses.
Most recently, he served as Vice President and Group Executive of the Life Sciences Innovations Group since 2021. Prior to that, Greg was President of Beckman Coulter Life Sciences, where he led significant growth and several successful acquisitions. He also held leadership roles in commercial operations and sales across various regions.
Greg holds a Bachelor of Science in Physics from the University of Puget Sound, graduating Summa Cum Laude.
